APA (7th ed.) Citation

LL, G., & CN, H. (2026). Combination treatments for myelofibrosis in JAK inhibitor-naive patients: Evidence, rationale, and clinical direction. Expert opinion on pharmacotherapy, 27(5), 439. https://doi.org/10.1080/14656566.2026.2654675

Chicago Style (17th ed.) Citation

LL, Gagnon, and Harrison CN. "Combination Treatments for Myelofibrosis in JAK Inhibitor-naive Patients: Evidence, Rationale, and Clinical Direction." Expert Opinion on Pharmacotherapy 27, no. 5 (2026): 439. https://doi.org/10.1080/14656566.2026.2654675.

MLA (9th ed.) Citation

LL, Gagnon, and Harrison CN. "Combination Treatments for Myelofibrosis in JAK Inhibitor-naive Patients: Evidence, Rationale, and Clinical Direction." Expert Opinion on Pharmacotherapy, vol. 27, no. 5, 2026, p. 439, https://doi.org/10.1080/14656566.2026.2654675.